Global Point of Care Diagnostics - POCD
Market Report
2023
Delivery Includes:- Market Timeline 2018 till 2030, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
Author Name: Anushka Gore | Report ID: CMR670608 | The base year for the calculation is 2023 and 2018 to 2023 will be historical period. The year 2023 will be estimated one while the forecasted data will be from year 2023 to 2028. When we deliver the report that time we updated report data till the purchase date. PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access. ![]()
Rating:4.8 | Review:7
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Point of Care Diagnostics - POCD Market Report 2023.
The global Point of Care diagnostics market was valued at USD 39.9 billion in 2022 and is projected to reach USD 59.4 billion by 2030, registering a CAGR of 5.1% for the forecast period 2023-2030.
Base Year | 2023 |
Historical Data Time Period | 2018-2023 |
Forecast Period | 2023-2030 |
Global Point of Care Diagnostics - POCD Market Sales Revenue 2022 | $ 39.9 |
Global Point of Care Diagnostics - POCD Market Sales Revenue 2030 | $ 59.4 |
Global Point of Care Diagnostics - POCD Market Compound Annual Growth Rate (CAGR) for 2023 to 2030 | 5.1% |
Point of Care Diagnostics - POCD Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Point-of-care testing (POCT) is a type of testing in which the analysis is carried out at the location where medical care is given to the patient or close by. Additional terms that have been used as alternatives include near patient testing (NPT), bedside testing, physician’s office testing (POL), off site testing, alternative site testing, etc. Point-of-care uses analytical tools to asses the results. The analytical devices include blood gas and critical care analysers. POCT is considered a preferable way rather than traditional testing. This testing has evolved around the globe due to its feasibility, performance and efficiency. It has a perceived ease of use as it is a near patient testing i.e., the patient can access the service any where without any prerequisite of laboratory. There are wide range of products that collect blood sample from the patients home and then taken to laboratory for the further testing.
The growing number of patients and the high disease rate has boosted the demand for point of care testing. The diseases like HIV, Covid-19 and other similar diseases have increased and thus the patients need faster response and adequate results without any complex procedures. For instance, the country with the highest reported use of POCT was France with 55 diseases, followed by Norway with 44 diseases. The demand for point of care testing is increasing at a moderate rate due to the direct relation with the chronic diseases.
The evolution and enhancement of a decentralised healthcare system has increased. Many hospitals are shifting from traditional healthcare to an innovative healthcare system. The diagnostics services are now not only provided at a particular hospital but are now deviated from hospitals to physician’s workplace, pharmacies and also done at patients home for a better feasibility. This decentralisation has been prevailing in boosting the demand for point of care testing market.
The technological advancements like the introduction of Lab-on-chip are the key driver of the point-of-care testing market. These technologies enable the results of infectious diseases at a faster rate and provide the diagnosis easier. The two main technologies used to determine a variety of characteristics, including cardiac indicators and infectious microorganisms, are glucose biosensor strips and lateral flow strips utilising immobilised antibodies. For instance, according to hypotheses, POCT is rising by at least 10–12% annually, with certain regions experiencing annual increases of 30% due to the advancement in technology.
The main concern in point of care testing is the quality control and quality assurance. The quality assurance is carried on by a complex procedure which cannot be cost effective. There cannot be any responsible person for quality assurance in this case of testing. The potential lack of reliability can be attributed to a variety of factors, including personnel variation, testing procedures and applications and the methodology’s perceived ease of use.
Point-of-care testing is more expensive as compared to the traditional diagnostics testing. The unit cost of point of care testing is more than the testing conducted in a traditional way or in a laboratory. For instance, POCT prices were from 1.1 to 4.6 times higher than central laboratory stat costs. In comparison to the central laboratory, the additional costs rise when POCT is utilised more frequently.
The world is coming closer through the use of cutting-edge technologies and innovations. The use of small and portable devices has increased due to high prevalence of feasibility and portability. The testing can be easily done anywhere without any location barrier. The increase of miniaturised technologies, the application of videoconferencing for remote monitoring, and the creation of less invasive and more continuous testing has been a trend for point-of-care testing. POCT enables detection of illnesses at an early stage by offering useful information at the time and location of care.
POCT devices are progressively being developed with the ability to connect and integrate with data management platforms, electronic health records, and healthcare information systems. Real-time test results transfer, smooth data processing, and improved patient care and monitoring are all made possible by this connectivity. According to the National Coordinator for Health Information Technology (ONC), in the United States, 78% of office-based doctors had HER technology certification as of 2021.
The pandemic had increased the demand for the Point of care diagnostics market. After the Covid-19 companies started to introduce new technologies and product for the rapid tests and quicker responses. A few months after the initial Covid-19 RT-PCR tests were implemented, POCT devices were introduced to the market to solve these problems. Covid-19 POC diagnostics, like the Abbott ID Now, which uses isothermal nucleic acid amplification, can offer results in 15 minutes or less despite having a lower capacity and enabling real-time diagnosis. For instance, the reverse transcription polymerase chain reaction (RT-PCR) test, which can accurately identify minute amounts of viral nucleic acid (SARS-CoV-2 RNA) in clinical specimens, is currently the gold standard for the diagnosis of acute SARS-CoV-2 infection. Thus, it had a positive impact on the point of care diagnostics market.
We have various report editions of Point of Care Diagnostics - POCD Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Many companies are involved in the designing of the new and innovative portable devices. For instance, in 2021, Siemens Healthcare launched product named Atellica VTLi Patient-Side Immunoassay Analyzer which will provide test results in 8 minutes using a patient's fingerstick blood sample.
Abbott introduces a molecular point of care test to predict the results faster. The U.S Food and Drug Administration has issued a notification regarding the faster diagnosis by molecular point of care test for the detection of the corona virus. The new launch assesses the positive results in 5 minutes whereas assess the negative results in just 13 minutes. The ID NOW platform uses molecular technology, which is highly esteemed by doctors and the scientific community for its high level of accuracy. It is compact, light, portable, and uses molecular analysis. The most frequently used molecular point-of-care testing tool in the United States is ID NOW.
Top Companies Market Share in Point of Care Diagnostics - POCD Industry: (In no particular order of Rank)
Global Point of Care Diagnostics - POCD Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Point of Care Diagnostics - POCD Industry growth. Point of Care Diagnostics - POCD market has been segmented with the help of its Product, Offering Platform, and others. Point of Care Diagnostics - POCD market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
The infectious diseases segment held the largest market share due to the growing chronic disease rate. This product can detect the virus or the disease in the minimal amount of time resulting in faster results. This provides the tests faster and easier. The other segments like Cardiac Markers, Cancer Marker, Lipid Testing has also observed a significant growth. Many companies are expanding their portfolio through this market. For instance, Cipla company launches a product named Cippoint, which offers different products which includes cardiac markers, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Point of Care Diagnostics - POCD Industry. Request a Free Sample PDF!
The growing use of AI and technologies, Software and services segment have held the largest market share. The adoption of MedTech and other integrated technologies have gained access to the growth in software services provided by the healthcare system.
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Point of Care Diagnostics - POCD market report 2023 Edition by contacting our team.
The market is fuelled by Pharmacy and Retail Clinic sector as regulatory agencies are increasing the validation/verification requirements for POC devices because of POCT utilisation rises in hospitals. The primary causes of the expansion of POC diagnostics applications include rising affordability, expanding healthcare coverage, and increasing availability to novel diagnostic technology.
North America accounted for the largest market share in the year 2022 due to the increase in the number of diseases and illness. North America has good infrastructure facilities, strong healthcare facilities and continuous expansion and innovation. There is use of cutting-edge point-of-care molecular diagnostics to identify diseases and infections, as well as an increase in research activity in this region. Growing numbers of people in the region are suffering from chronic diseases, and there are more procedures performed annually. North America has high healthcare expenditure particularly in United states. North America also has favourable regulatory environment with lesser complex procedures. This results in launch of new point of care testing products into the market and also assures the quality and standard of the product.
The current report Scope analyzes Point of Care Diagnostics - POCD Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Market Split by Product |
|
Market Split by Offering |
|
Market Split by Platform |
|
Market Split by Sample Type |
|
Market Split by End Use |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Point of Care Diagnostics - POCD industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Segmentation Level Customization | |
Global level Data Customization | |
Region level Data Customization | |
Country level Data Customization | |
Company Level | |
Additional Data Analysis | |
Additional Qualitative Data | |
Additional Quantitative Data | |
Service Level Customization | Report Format Alteration |
We offer multiple report editions and also support 100% data customization! Currently, we have listed the Table of Contents for your reference and you can order this report off the shelf OR you can customize the report edition to suit your exact data needs.
(Please Note, It is possible to deliver only certain data pointer/s, section/s, Chapter/s, OR Page/s instead of the full report, get in touch with sales team at sales@cognitivemarketresearch.com)
This is a revenue specific report edition where the data is restricted only for the revenue.The pricing are according to the user license selection single user license: $2,445.00 USD, Team user license: $4,545.00 USD and Corporate user license:$6,845.00 USD On request we can arrange the copies depending the payment made from your side.
This is a revenue and volume specific report edition where the data is restricted for the revenue and volume.The pricing are according to the user license selection single user license: $3,445.00 USD, Team user license: $5,545.00 USD and Corporate user license:$7,845.00 USD On request we can arrange the copies depending the payment made from your side.
This is a volume specific report edition where the data is restricted only for the volume.The pricing are according to the user license selection single user license: $2,945.00 USD, Team user license: $5,045.00 USD and Corporate user license:$7,345.00 USD On request we can arrange the copies depending the payment made from your side.
This chapter helps you to understand the importance of report and how we designed the report scope of Point of Care Diagnostics - POCD market. As per your requirement we can also design the market scope as a customised report.
This chapter provides insights on our data collection and data validation process. It covers detailed information on wide range of sources referred during the study.
We have designed a unique questionnaire for the market research survey of Point of Care Diagnostics - POCD industry and shared it with a network of Industry experts of the entire value chain, located across the globe. This study helps us to gather accurate quantitative and qualitative data for the publication.
The executive summary is an overview of a Point of Care Diagnostics - POCD Market Report. In this chapter we have summarized the overall report data in snapshot format.
This chapters incorporated product description overview and regional sales statistics for the year 2018-2030.
This chapter covers a competitive analysis of the global Point of Care Diagnostics - POCD market, and it includes quantitative information such as revenue and market share of the manufacturers. The chapter also includes information regarding the strategies adopted by the manufacturers such as mergers, acquisitions, and new product launches.
ESG analysis is the consideration of all factors in investment including environmental, social, and governance (ESG) factors. ESG integration is key part of the investment process. ESG analysis helps to measure company’s goals and progress when it comes to climate change, social improvement and good governance.
This chapter helps you understand the Market Drivers, Market Restrain, Market Opportunity and Trends by each segment.
This segment of the report provides in-depth and pertinent information on every foremost player in the market through both primary and secondary research. The Company Basic Information, and Sales Area chapter includes ten or more key players, which are dominating the market. Each company profile includes demystifying professional information in a tabular format, which comprises the company’s official website, established year, market position, geographical presence, competitors, and contact information. Further, company profiling includes an in-detailed business overview, COVID-19 impact on the particular firm, product type specifications, revenue & market share, and recent developments done by the company for its inorganic development, such as mergers, strategic acquisitions, partnerships, and others. Besides, profiling includes the company’s investment in research and development activities. The recent innovative product launches, business expansion, investments done by the company in different markets, and other news are also available in the company profiling section. At last, it provides the company’s business strategy and SWOT analysis.
This chapter covers in-detailed insights regarding type segments to understand consumer interests and provide a revenue stream for each type. Type segment analysis help in making a better business decision to maximize profitability by focusing resources on those market type that are relatively favorable to their goals.
This chapter covers in-detailed insights regarding type segments to understand consumer interests and provide a revenue stream for each type. Type segment analysis help in making a better business decision to maximize profitability by focusing resources on those market type that are relatively favorable to their goals.
This chapter covers in-detailed insights regarding type segments to understand consumer interests and provide a revenue stream for each type. Type segment analysis help in making a better business decision to maximize profitability by focusing resources on those market type that are relatively favorable to their goals.
This chapter covers in-detailed insights regarding type segments to understand consumer interests and provide a revenue stream for each type. Type segment analysis help in making a better business decision to maximize profitability by focusing resources on those market type that are relatively favorable to their goals.
This chapter covers in-detailed insights regarding type segments to understand consumer interests and provide a revenue stream for each type. Type segment analysis help in making a better business decision to maximize profitability by focusing resources on those market type that are relatively favorable to their goals.
This chapter categorizes detailed perceptions into an application segment based on end users’ needs, and preferences to understand their requirements and purchasing patterns effectively. It analyzes the current trends of the market that mainly consists of information related to new product use, trends in consumer demand, and available close substitutes of the product.
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Point of Care Diagnostics - POCD market
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Point of Care Diagnostics - POCD Market is witnessing significant growth in the near future.
In 2023, the Glucose Testing segment accounted for noticeable share of global Point of Care Diagnostics - POCD Market and is projected to experience significant growth in the near future.
The Consumables segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Danaher; Qiagen; Abbott; Siemens Healthcare AG; F. Hoffmann-La Roche Ltd.; bioMerieux SA; Nova Biomedical; Quidel Corp.; Sekisui Diagnostics; Trinity Biotech., and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Why Glucose Testing have a significant impact on Point of Care Diagnostics - POCD market? |
What are the key factors affecting the Glucose Testing and Hb1Ac Testing of Point of Care Diagnostics - POCD Market? |
What is the CAGR/Growth Rate of Consumables during the forecast period? |
By type, which segment accounted for largest share of the global Point of Care Diagnostics - POCD Market? |
Which region is expected to dominate the global Point of Care Diagnostics - POCD Market within the forecast period? |
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Point of Care Diagnostics - POCD Market
Request Sample
Global Report Edition includes data about 5 major regions and a total of 36 countries. Please refer to the Table of Contents tab. If you require customized data our research team will assist you and provide you with an exclusive report edition delivery. You can also purchase regional and country-level data edition/s. Please get in contact with us prior to making a purchase sales@cognitivemarketresearch.com.
The regional report edition will help you get the data specific to the to selected region from the drop down.
The country specific report edition and the respective table of content will be delivered to you as per your enquiry or you can refer the following link for the same.
We do not store your personal details or this web session! By using our website, you agree to our user privacy policy developed considering user data protection laws. Please acknowledge this by clicking the button Below!